Shares of Acadia Healthcare Co. (NASDAQ:ACHC) rose 3.8% on Thursday . The company traded as high as $54.58 and last traded at $53.25, with a volume of 1,611,905 shares traded. The stock had previously closed at $51.29.

Several analysts recently commented on the stock. Jefferies Group reissued a “buy” rating and set a $85.00 target price on shares of Acadia Healthcare in a research note on Monday, June 27th. Leerink Swann reissued an “outperform” rating and set a $90.00 target price on shares of Acadia Healthcare in a research note on Friday, July 15th. Robert W. Baird reissued an “outperform” rating and set a $69.00 target price on shares of Acadia Healthcare in a research note on Tuesday, June 14th. Zacks Investment Research lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, July 11th. Finally, Cantor Fitzgerald reissued a “buy” rating on shares of Acadia Healthcare in a research note on Friday, April 29th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $79.33.

The company has a market cap of $4.94 billion and a PE ratio of 33.59. The firm’s 50-day moving average is $55.72 and its 200-day moving average is $57.06.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Friday, July 29th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.73. The business had revenue of $756.50 million for the quarter, compared to the consensus estimate of $752.57 million. During the same period in the previous year, the company earned $0.57 earnings per share. The company’s revenue for the quarter was up 66.8% compared to the same quarter last year. Equities research analysts expect that Acadia Healthcare Co. will post $2.82 earnings per share for the current year.

Several hedge funds and institutional investors have made changes to their positions in ACHC. Rhumbline Advisers increased its position in shares of Acadia Healthcare by 6.1% in the fourth quarter. Rhumbline Advisers now owns 53,198 shares of the company’s stock worth $3,323,000 after buying an additional 3,045 shares during the last quarter. California Public Employees Retirement System increased its position in shares of Acadia Healthcare by 0.9% in the fourth quarter. California Public Employees Retirement System now owns 82,700 shares of the company’s stock worth $5,165,000 after buying an additional 700 shares during the last quarter. New York State Common Retirement Fund increased its position in shares of Acadia Healthcare by 11.3% in the fourth quarter. New York State Common Retirement Fund now owns 190,543 shares of the company’s stock worth $11,901,000 after buying an additional 19,337 shares during the last quarter. Mutual of America Capital Management LLC increased its position in shares of Acadia Healthcare by 0.3% in the fourth quarter. Mutual of America Capital Management LLC now owns 57,344 shares of the company’s stock worth $3,582,000 after buying an additional 194 shares during the last quarter. Finally, Bank of Montreal Can increased its position in shares of Acadia Healthcare by 17.6% in the fourth quarter. Bank of Montreal Can now owns 349,672 shares of the company’s stock worth $21,841,000 after buying an additional 52,353 shares during the last quarter.

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.